378 labs billed Medicare at questionable levels for COVID-19 tests, OIG report says

A Dec. 6 OIG report found that 378 labs billed Medicare Part B at questionably high levels for test add-ons.

Advertisement

The report found 276 labs that billed for high volumes of add-on tests on claims for COVID-19 tests and 263 labs that billed for high payment amounts from add-on tests on claims for COVID-19 tests.

One lab billed an average per claim of $666 covering both COVID-19 tests and add-on tests, compared to an average of $89 for all other labs billed for both COVID-19 and add-on tests. 

The report concluded that further billing scrutiny of these labs is needed, and the OIG referred the 378 labs to CMS.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.